エピソード

  • Transforming Healthcare with Responsible AI: A Conversation with David Rhew, Microsoft’s Global Chief Medical Officer
    2025/07/21

    In this episode of Decoded, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Dr. David Rhew, Global Chief Medical Officer at Microsoft and adjunct professor at Stanford University, to explore how responsible AI, multimodal data, and collective intelligence are reshaping global healthcare.

    From his early fascination with arcade games to his leadership at Microsoft, Dr. Rhew shares a unique journey that blends computer science, clinical practice, and visionary health technology.

    Together, they explore:

    • Why building trust in AI is fundamental to healthcare transformation
    • What multimodal data means for personalized, predictive medicine
    • How technology can drive equity and scale across underserved regions
    • The cultural and regulatory barriers that still stand in the way

    Dr. Rhew also offers timely insights on what the next decade holds for diagnostics, prescribing, and healthcare collaboration - and his advice for the next generation of innovators in technology and medicine.

    This is a candid, visionary conversation about the future of care: data-powered, human-centered, and globally connected.

    続きを読む 一部表示
    36 分
  • Liquid Biopsy Decoded: Data, Diagnostics, and the Future of Cancer Care
    2025/06/23

    How do we move from discovery to action in the fight against cancer?

    In this inaugural episode of the Decoded podcast, Dr. Jurgi Camblong speaks with Professor Umberto Malapelle, one of the leading voices in molecular diagnostics and liquid biopsy, to explore how precision data is reshaping the fight against cancer.

    Together, they decode the evolving role of pathology, tracing the shift from glass slides to genomic signals and the rise of liquid biopsy as a dynamic, non-invasive tool in cancer care.

    Professor Malapelle reveals how integrating molecular insights is making diagnostics more precise, accessible, and equitable - while empowering clinicians to personalize treatment at scale.

    The conversation unpacks the real-world impact of liquid biopsy, the economics of molecular testing, and why the future of cancer care depends on both collaboration and a new generation of digitally fluent healthcare professionals.

    Listen in for:

    • Insights on where cancer diagnostics is heading
    • The power - and challenge - of integrating complex data in medicine
    • Why liquid biopsy is more than a buzzword

    This is the future of oncology, decoded.

    Explore more: https://www.sophiagenetics.com/podcasts/

    続きを読む 一部表示
    24 分